Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.74379474 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.74379474 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.23169533 |
4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.67246023 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.38598327 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.38598327 |
7 | modulation by symbiont of host immune response (GO:0052553) | 5.38598327 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 5.38598327 |
9 | modulation by symbiont of host defense response (GO:0052031) | 5.38598327 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.38598327 |
11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.95594663 |
12 | positive regulation of interferon-alpha production (GO:0032727) | 4.91452118 |
13 | response to type I interferon (GO:0034340) | 4.69833309 |
14 | regulation of interferon-alpha production (GO:0032647) | 4.68765610 |
15 | cellular response to type I interferon (GO:0071357) | 4.64446877 |
16 | type I interferon signaling pathway (GO:0060337) | 4.64446877 |
17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.34212124 |
18 | regulation of gamma-delta T cell activation (GO:0046643) | 4.18116742 |
19 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.15111993 |
20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.12044227 |
21 | detection of other organism (GO:0098543) | 3.95891546 |
22 | negative regulation of T cell mediated immunity (GO:0002710) | 3.94638703 |
23 | response to interferon-alpha (GO:0035455) | 3.84597680 |
24 | detection of bacterium (GO:0016045) | 3.80841723 |
25 | macrophage activation involved in immune response (GO:0002281) | 3.80694290 |
26 | response to host immune response (GO:0052572) | 3.80209270 |
27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.80209270 |
28 | T cell migration (GO:0072678) | 3.79464207 |
29 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.71195181 |
30 | response to interleukin-15 (GO:0070672) | 3.68690119 |
31 | positive regulation of interferon-beta production (GO:0032728) | 3.60587504 |
32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58402289 |
33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.57730088 |
34 | lymphocyte chemotaxis (GO:0048247) | 3.56998735 |
35 | cellular response to interleukin-15 (GO:0071350) | 3.56082232 |
36 | response to host (GO:0075136) | 3.55596366 |
37 | response to host defenses (GO:0052200) | 3.55596366 |
38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.55596366 |
39 | immunoglobulin mediated immune response (GO:0016064) | 3.53620360 |
40 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.53393030 |
41 | positive regulation of type 2 immune response (GO:0002830) | 3.53122851 |
42 | response to peptidoglycan (GO:0032494) | 3.50351142 |
43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.50110754 |
44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.49049406 |
45 | negative regulation of cell killing (GO:0031342) | 3.49049406 |
46 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.48877577 |
47 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.48527853 |
48 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.44364002 |
49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.42246119 |
50 | cytidine metabolic process (GO:0046087) | 3.41169405 |
51 | cytidine catabolic process (GO:0006216) | 3.41169405 |
52 | cytidine deamination (GO:0009972) | 3.41169405 |
53 | detection of external biotic stimulus (GO:0098581) | 3.38181597 |
54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.38137708 |
55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.34161365 |
56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31260864 |
57 | positive thymic T cell selection (GO:0045059) | 3.29468630 |
58 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28851733 |
59 | neutrophil activation (GO:0042119) | 3.28417012 |
60 | negative T cell selection (GO:0043383) | 3.26792739 |
61 | detection of molecule of bacterial origin (GO:0032490) | 3.26583250 |
62 | regulation of regulatory T cell differentiation (GO:0045589) | 3.23336635 |
63 | cellular response to interferon-beta (GO:0035458) | 3.20771568 |
64 | negative thymic T cell selection (GO:0045060) | 3.17543014 |
65 | cellular response to virus (GO:0098586) | 3.17105593 |
66 | NIK/NF-kappaB signaling (GO:0038061) | 3.15696580 |
67 | cellular extravasation (GO:0045123) | 3.13204092 |
68 | cellular response to interferon-alpha (GO:0035457) | 3.11619586 |
69 | defense response to protozoan (GO:0042832) | 3.11320921 |
70 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.10840337 |
71 | I-kappaB phosphorylation (GO:0007252) | 3.10734016 |
72 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.10505202 |
73 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10206545 |
74 | positive regulation of B cell differentiation (GO:0045579) | 3.10091398 |
75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09089598 |
76 | neutrophil activation involved in immune response (GO:0002283) | 3.06351118 |
77 | positive regulation of humoral immune response (GO:0002922) | 3.06276661 |
78 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.06012637 |
79 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05675506 |
80 | response to muramyl dipeptide (GO:0032495) | 3.03530778 |
81 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02549134 |
82 | negative regulation of viral genome replication (GO:0045071) | 3.02532886 |
83 | myeloid dendritic cell differentiation (GO:0043011) | 3.01388838 |
84 | regulation of tolerance induction (GO:0002643) | 3.00537001 |
85 | regulation of response to interferon-gamma (GO:0060330) | 2.99716839 |
86 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.99045109 |
87 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.99045109 |
88 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.98313097 |
89 | natural killer cell mediated immunity (GO:0002228) | 2.98313097 |
90 | regulation of type 2 immune response (GO:0002828) | 2.96828615 |
91 | leukocyte aggregation (GO:0070486) | 2.96751459 |
92 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.96526188 |
93 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94546266 |
94 | detection of biotic stimulus (GO:0009595) | 2.93836402 |
95 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.93623142 |
96 | response to protozoan (GO:0001562) | 2.93283976 |
97 | respiratory burst (GO:0045730) | 2.93060887 |
98 | negative regulation of interleukin-12 production (GO:0032695) | 2.92574816 |
99 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.92451643 |
100 | cellular response to exogenous dsRNA (GO:0071360) | 2.89637547 |
101 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.88672723 |
102 | myeloid cell activation involved in immune response (GO:0002275) | 2.88548075 |
103 | regulation of RIG-I signaling pathway (GO:0039535) | 2.86336351 |
104 | germinal center formation (GO:0002467) | 2.85073512 |
105 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.84971130 |
106 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.84067149 |
107 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.83820646 |
108 | positive regulation of lymphocyte migration (GO:2000403) | 2.83481705 |
109 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.81818882 |
110 | regulation of interferon-beta production (GO:0032648) | 2.80857518 |
111 | cellular response to interferon-gamma (GO:0071346) | 2.78935291 |
112 | interferon-gamma production (GO:0032609) | 2.78622032 |
113 | microglial cell activation (GO:0001774) | 2.78412559 |
114 | regulation of B cell differentiation (GO:0045577) | 2.78309340 |
115 | regulation of antigen processing and presentation (GO:0002577) | 2.77959300 |
116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.77166202 |
117 | natural killer cell differentiation (GO:0001779) | 2.74986583 |
118 | response to interferon-beta (GO:0035456) | 2.74171243 |
119 | B cell receptor signaling pathway (GO:0050853) | 2.73904512 |
120 | T cell selection (GO:0045058) | 2.72227333 |
121 | regulation of T cell tolerance induction (GO:0002664) | 2.72194999 |
122 | positive regulation of T cell cytokine production (GO:0002726) | 2.71998556 |
123 | pinocytosis (GO:0006907) | 2.70795078 |
124 | B cell mediated immunity (GO:0019724) | 2.69932547 |
125 | positive T cell selection (GO:0043368) | 2.69412414 |
126 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.69166908 |
127 | defense response to virus (GO:0051607) | 2.68347804 |
128 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.68256960 |
129 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.66770841 |
130 | leukocyte cell-cell adhesion (GO:0007159) | 2.66418024 |
131 | thymic T cell selection (GO:0045061) | 2.64792711 |
132 | T-helper 1 type immune response (GO:0042088) | 2.63405055 |
133 | tolerance induction (GO:0002507) | 2.61940373 |
134 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.61591201 |
135 | myeloid dendritic cell activation (GO:0001773) | 2.60911049 |
136 | granulocyte activation (GO:0036230) | 2.58292856 |
137 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.56719456 |
138 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.55870858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.41129117 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.15906193 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.00057768 |
4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.93051198 |
5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.22708673 |
6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.88968222 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.51202856 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22194217 |
9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13238740 |
10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10685203 |
11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.02188557 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.93879400 |
13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.93520898 |
14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85783649 |
15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.62984405 |
16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49608636 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.49149360 |
18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.39704486 |
19 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.24701989 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.19865501 |
21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.17137330 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17005837 |
23 | MAF_26560356_Chip-Seq_TH1_Human | 2.16950966 |
24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.15968794 |
25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.14902243 |
26 | MYC_22102868_ChIP-Seq_BL_Human | 2.04379031 |
27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01527964 |
28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00736385 |
29 | MYB_26560356_Chip-Seq_TH1_Human | 1.94837612 |
30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88358973 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88154512 |
32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87006358 |
33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85468307 |
34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.79295723 |
35 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77748560 |
36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.76722683 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74735390 |
38 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.72238532 |
39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71229969 |
40 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66102490 |
41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64347509 |
42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63506415 |
43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58695382 |
44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58390749 |
45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56997602 |
46 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.55089896 |
47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51488982 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.51463249 |
49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.51202759 |
50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49617656 |
51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47992225 |
52 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.47057051 |
53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45073276 |
54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42478267 |
55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40139680 |
56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32046725 |
57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29580563 |
58 | MAF_26560356_Chip-Seq_TH2_Human | 1.26556621 |
59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25086921 |
60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23225051 |
61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22991831 |
62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18712339 |
63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18598489 |
64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18449018 |
65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18220744 |
66 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17945603 |
67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15348548 |
68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12866282 |
69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10980365 |
70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09368015 |
71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09140009 |
72 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08172333 |
73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05097152 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03761863 |
75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00579042 |
76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00553670 |
77 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99933889 |
78 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99889907 |
79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99877322 |
80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97470505 |
81 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.97353073 |
82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96375706 |
83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95505321 |
84 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94774569 |
85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94512928 |
86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92537776 |
87 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91637317 |
88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91515745 |
89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91321264 |
90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90547515 |
91 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89737664 |
92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86923389 |
93 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.86137624 |
94 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85660326 |
95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85253460 |
96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.84938437 |
97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84594921 |
98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84156086 |
99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82782775 |
100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81245974 |
101 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81090699 |
102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81020672 |
103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80996284 |
104 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80408593 |
105 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80253980 |
106 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.79496465 |
107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79147977 |
108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79079414 |
109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79043691 |
110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78927447 |
111 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.76272942 |
112 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.75273125 |
113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74702288 |
114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73319227 |
115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72462026 |
116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.72285670 |
117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72023652 |
118 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.71576002 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.93895513 |
2 | MP0009785_altered_susceptibility_to | 3.14291482 |
3 | MP0003436_decreased_susceptibility_to | 2.99987580 |
4 | MP0000685_abnormal_immune_system | 2.99745497 |
5 | MP0003303_peritoneal_inflammation | 2.97833943 |
6 | MP0001790_abnormal_immune_system | 2.94799323 |
7 | MP0005387_immune_system_phenotype | 2.94799323 |
8 | MP0001800_abnormal_humoral_immune | 2.77053650 |
9 | MP0003724_increased_susceptibility_to | 2.69840572 |
10 | MP0006082_CNS_inflammation | 2.67756145 |
11 | * MP0005000_abnormal_immune_tolerance | 2.67626826 |
12 | MP0005671_abnormal_response_to | 2.65105448 |
13 | MP0005025_abnormal_response_to | 2.62988331 |
14 | MP0003300_gastrointestinal_ulcer | 2.56687907 |
15 | MP0002452_abnormal_antigen_presenting | 2.50703968 |
16 | MP0002419_abnormal_innate_immunity | 2.47381215 |
17 | * MP0002723_abnormal_immune_serum | 2.41052207 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.32518579 |
19 | * MP0001819_abnormal_immune_cell | 2.19718806 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.18535507 |
21 | MP0002166_altered_tumor_susceptibility | 2.06819983 |
22 | MP0005058_abnormal_lysosome_morphology | 2.06704320 |
23 | * MP0004947_skin_inflammation | 2.05662241 |
24 | MP0003763_abnormal_thymus_physiology | 2.01858006 |
25 | MP0004510_myositis | 1.98945491 |
26 | MP0005464_abnormal_platelet_physiology | 1.94861207 |
27 | MP0010155_abnormal_intestine_physiology | 1.93591321 |
28 | * MP0002398_abnormal_bone_marrow | 1.83739447 |
29 | MP0001853_heart_inflammation | 1.82484541 |
30 | MP0005451_abnormal_body_composition | 1.81317860 |
31 | * MP0000716_abnormal_immune_system | 1.78698553 |
32 | MP0002006_tumorigenesis | 1.76855155 |
33 | * MP0001845_abnormal_inflammatory_respons | 1.76084828 |
34 | MP0002405_respiratory_system_inflammati | 1.74903511 |
35 | MP0001533_abnormal_skeleton_physiology | 1.72387464 |
36 | MP0009840_abnormal_foam_cell | 1.65793378 |
37 | MP0009278_abnormal_bone_marrow | 1.63583202 |
38 | * MP0008469_abnormal_protein_level | 1.60967753 |
39 | * MP0000689_abnormal_spleen_morphology | 1.57794734 |
40 | MP0003172_abnormal_lysosome_physiology | 1.57605101 |
41 | MP0003191_abnormal_cellular_cholesterol | 1.48715466 |
42 | * MP0002722_abnormal_immune_system | 1.48687683 |
43 | MP0009333_abnormal_splenocyte_physiolog | 1.48612215 |
44 | MP0008260_abnormal_autophagy | 1.47170636 |
45 | * MP0002429_abnormal_blood_cell | 1.46505830 |
46 | MP0009764_decreased_sensitivity_to | 1.44908842 |
47 | MP0003448_altered_tumor_morphology | 1.39650076 |
48 | MP0001873_stomach_inflammation | 1.36559375 |
49 | MP0005360_urolithiasis | 1.32985957 |
50 | MP0002139_abnormal_hepatobiliary_system | 1.31396409 |
51 | MP0001545_abnormal_hematopoietic_system | 1.29762241 |
52 | MP0005397_hematopoietic_system_phenotyp | 1.29762241 |
53 | MP0010307_abnormal_tumor_latency | 1.28485156 |
54 | MP0002396_abnormal_hematopoietic_system | 1.27486299 |
55 | MP0004808_abnormal_hematopoietic_stem | 1.25255678 |
56 | MP0003806_abnormal_nucleotide_metabolis | 1.24515342 |
57 | MP0010352_gastrointestinal_tract_polyps | 1.24347833 |
58 | MP0000569_abnormal_digit_pigmentation | 1.23621762 |
59 | MP0000703_abnormal_thymus_morphology | 1.18411000 |
60 | MP0003705_abnormal_hypodermis_morpholog | 1.18071663 |
61 | MP0002138_abnormal_hepatobiliary_system | 1.15459788 |
62 | MP0002933_joint_inflammation | 1.14859680 |
63 | MP0000343_altered_response_to | 1.14764356 |
64 | MP0002132_abnormal_respiratory_system | 1.13965923 |
65 | MP0002998_abnormal_bone_remodeling | 1.13849426 |
66 | MP0009763_increased_sensitivity_to | 1.12913194 |
67 | MP0000609_abnormal_liver_physiology | 1.10496777 |
68 | MP0000858_altered_metastatic_potential | 1.10223931 |
69 | MP0000604_amyloidosis | 1.09274108 |
70 | MP0000465_gastrointestinal_hemorrhage | 1.07754821 |
71 | MP0005310_abnormal_salivary_gland | 1.06419487 |
72 | MP0005023_abnormal_wound_healing | 1.06389073 |
73 | MP0003566_abnormal_cell_adhesion | 1.04128232 |
74 | MP0003075_altered_response_to | 1.02125334 |
75 | MP0003453_abnormal_keratinocyte_physiol | 1.00366092 |
76 | MP0004883_abnormal_blood_vessel | 1.00115393 |
77 | MP0005083_abnormal_biliary_tract | 0.97305886 |
78 | MP0002277_abnormal_respiratory_mucosa | 0.96045641 |
79 | MP0005076_abnormal_cell_differentiation | 0.95823556 |
80 | MP0003252_abnormal_bile_duct | 0.93387861 |
81 | MP0005365_abnormal_bile_salt | 0.92901553 |
82 | MP0003866_abnormal_defecation | 0.89985481 |
83 | MP0008004_abnormal_stomach_pH | 0.89350891 |
84 | MP0003091_abnormal_cell_migration | 0.89250747 |
85 | MP0005166_decreased_susceptibility_to | 0.89119929 |
86 | MP0001851_eye_inflammation | 0.88206870 |
87 | MP0003045_fibrosis | 0.86944334 |
88 | MP0006054_spinal_hemorrhage | 0.85571012 |
89 | MP0000490_abnormal_crypts_of | 0.82296655 |
90 | MP0001663_abnormal_digestive_system | 0.78267292 |
91 | MP0003690_abnormal_glial_cell | 0.77884127 |
92 | MP0000249_abnormal_blood_vessel | 0.76442716 |
93 | MP0000598_abnormal_liver_morphology | 0.74248800 |
94 | MP0003828_pulmonary_edema | 0.73593748 |
95 | MP0003183_abnormal_peptide_metabolism | 0.73368346 |
96 | MP0010329_abnormal_lipoprotein_level | 0.72837429 |
97 | MP0005319_abnormal_enzyme/_coenzyme | 0.72073890 |
98 | MP0002332_abnormal_exercise_endurance | 0.71430422 |
99 | MP0009765_abnormal_xenobiotic_induced | 0.70866983 |
100 | MP0002254_reproductive_system_inflammat | 0.70387095 |
101 | * MP0002136_abnormal_kidney_physiology | 0.70085381 |
102 | MP0004381_abnormal_hair_follicle | 0.69977099 |
103 | MP0005390_skeleton_phenotype | 0.69850727 |
104 | MP0005164_abnormal_response_to | 0.69526344 |
105 | MP0003795_abnormal_bone_structure | 0.68694973 |
106 | MP0004185_abnormal_adipocyte_glucose | 0.68211093 |
107 | MP0002019_abnormal_tumor_incidence | 0.67567865 |
108 | MP0005085_abnormal_gallbladder_physiolo | 0.67550627 |
109 | MP0003656_abnormal_erythrocyte_physiolo | 0.66146256 |
110 | MP0000371_diluted_coat_color | 0.65823098 |
111 | MP0004130_abnormal_muscle_cell | 0.65528155 |
112 | MP0005174_abnormal_tail_pigmentation | 0.65339761 |
113 | MP0005167_abnormal_blood-brain_barrier | 0.61331491 |
114 | MP0005165_increased_susceptibility_to | 0.60364526 |
115 | MP0002877_abnormal_melanocyte_morpholog | 0.59531539 |
116 | MP0001542_abnormal_bone_strength | 0.59319219 |
117 | MP0005075_abnormal_melanosome_morpholog | 0.58569019 |
118 | MP0008874_decreased_physiological_sensi | 0.56399652 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.95656977 |
2 | Recurrent abscess formation (HP:0002722) | 4.51638360 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.40203498 |
4 | Chronic otitis media (HP:0000389) | 4.35864023 |
5 | Recurrent viral infections (HP:0004429) | 4.29390031 |
6 | Recurrent bacterial skin infections (HP:0005406) | 4.22469185 |
7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.96445251 |
8 | Autoimmune thrombocytopenia (HP:0001973) | 3.95871041 |
9 | Myositis (HP:0100614) | 3.91885588 |
10 | Recurrent fungal infections (HP:0002841) | 3.87942982 |
11 | Encephalitis (HP:0002383) | 3.87163337 |
12 | Nasal polyposis (HP:0100582) | 3.67140123 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 3.60062383 |
14 | Recurrent bronchitis (HP:0002837) | 3.58415130 |
15 | Orchitis (HP:0100796) | 3.53567203 |
16 | T lymphocytopenia (HP:0005403) | 3.49457623 |
17 | Abnormality of T cell number (HP:0011839) | 3.46129370 |
18 | Systemic lupus erythematosus (HP:0002725) | 3.44876839 |
19 | Vasculitis (HP:0002633) | 3.42965637 |
20 | Abnormality of the nasal mucosa (HP:0000433) | 3.40534445 |
21 | Abnormality of macrophages (HP:0004311) | 3.36765726 |
22 | Recurrent skin infections (HP:0001581) | 3.21307984 |
23 | Optic neuritis (HP:0100653) | 3.17543479 |
24 | Retrobulbar optic neuritis (HP:0100654) | 3.17543479 |
25 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.12319178 |
26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.12319178 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.12319178 |
28 | Stomatitis (HP:0010280) | 3.05170071 |
29 | Pustule (HP:0200039) | 3.02471286 |
30 | Gangrene (HP:0100758) | 2.98712514 |
31 | Myocardial infarction (HP:0001658) | 2.94258019 |
32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.93901334 |
33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.93901334 |
34 | Interstitial pulmonary disease (HP:0006530) | 2.92326915 |
35 | Gingival bleeding (HP:0000225) | 2.87395556 |
36 | Vacuolated lymphocytes (HP:0001922) | 2.85257930 |
37 | Cellulitis (HP:0100658) | 2.82911818 |
38 | Abnormality of T cells (HP:0002843) | 2.81611602 |
39 | Hematochezia (HP:0002573) | 2.80184768 |
40 | Basal ganglia calcification (HP:0002135) | 2.76149502 |
41 | Spontaneous hematomas (HP:0007420) | 2.74625015 |
42 | Arterial thrombosis (HP:0004420) | 2.73952537 |
43 | Periodontitis (HP:0000704) | 2.73705809 |
44 | Gingivitis (HP:0000230) | 2.71975079 |
45 | Increased cerebral lipofuscin (HP:0011813) | 2.71484009 |
46 | Pulmonary infiltrates (HP:0002113) | 2.69922353 |
47 | Meningitis (HP:0001287) | 2.69782173 |
48 | Colitis (HP:0002583) | 2.68768175 |
49 | Abnormality of the pleura (HP:0002103) | 2.59176494 |
50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.57938513 |
51 | Inflammation of the large intestine (HP:0002037) | 2.56619332 |
52 | Eosinophilia (HP:0001880) | 2.52557936 |
53 | Leukocytosis (HP:0001974) | 2.50678922 |
54 | Gastrointestinal inflammation (HP:0004386) | 2.46605161 |
55 | IgG deficiency (HP:0004315) | 2.44510515 |
56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44434197 |
57 | Obstructive lung disease (HP:0006536) | 2.44434197 |
58 | Hemoptysis (HP:0002105) | 2.42336506 |
59 | Gastrointestinal infarctions (HP:0005244) | 2.42115061 |
60 | Polyneuropathy (HP:0001271) | 2.36762857 |
61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.36701870 |
62 | Lymphopenia (HP:0001888) | 2.35021923 |
63 | Abnormality of the pericardium (HP:0001697) | 2.34425272 |
64 | Keratitis (HP:0000491) | 2.32753888 |
65 | Glomerulopathy (HP:0100820) | 2.32209445 |
66 | IgM deficiency (HP:0002850) | 2.32086946 |
67 | Increased IgE level (HP:0003212) | 2.31597408 |
68 | Emphysema (HP:0002097) | 2.30855076 |
69 | Chronic sinusitis (HP:0011109) | 2.30373477 |
70 | Joint swelling (HP:0001386) | 2.30229595 |
71 | Autoimmune hemolytic anemia (HP:0001890) | 2.30218695 |
72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.28226163 |
73 | Hypergammaglobulinemia (HP:0010702) | 2.27752263 |
74 | Panhypogammaglobulinemia (HP:0003139) | 2.26954499 |
75 | Osteomyelitis (HP:0002754) | 2.26827258 |
76 | Abnormality of T cell physiology (HP:0011840) | 2.26771206 |
77 | Joint hemorrhage (HP:0005261) | 2.26474860 |
78 | Agammaglobulinemia (HP:0004432) | 2.24990270 |
79 | Hepatosplenomegaly (HP:0001433) | 2.24721256 |
80 | Keratoconjunctivitis sicca (HP:0001097) | 2.24316951 |
81 | Abnormality of the endocardium (HP:0004306) | 2.23501366 |
82 | Tetraparesis (HP:0002273) | 2.22568368 |
83 | Increased serum ferritin (HP:0003281) | 2.22412809 |
84 | Gastrointestinal stroma tumor (HP:0100723) | 2.21628412 |
85 | Epistaxis (HP:0000421) | 2.21577072 |
86 | Purpura (HP:0000979) | 2.20457460 |
87 | Chronic diarrhea (HP:0002028) | 2.19042439 |
88 | Episodic fever (HP:0001954) | 2.18298110 |
89 | Acne (HP:0001061) | 2.17895609 |
90 | Increased IgM level (HP:0003496) | 2.17110110 |
91 | Pulmonary embolism (HP:0002204) | 2.14717639 |
92 | Granulocytopenia (HP:0001913) | 2.13939973 |
93 | Glomerulonephritis (HP:0000099) | 2.13611728 |
94 | Complement deficiency (HP:0004431) | 2.13430891 |
95 | Axonal loss (HP:0003447) | 2.11887296 |
96 | Thrombophlebitis (HP:0004418) | 2.11324554 |
97 | IgA deficiency (HP:0002720) | 2.11104955 |
98 | Esophageal varix (HP:0002040) | 2.10835455 |
99 | Nephritis (HP:0000123) | 2.10770426 |
100 | Dysostosis multiplex (HP:0000943) | 2.09661304 |
101 | Hypochromic anemia (HP:0001931) | 2.08755488 |
102 | Amyloidosis (HP:0011034) | 2.08543247 |
103 | Premature loss of primary teeth (HP:0006323) | 2.07904031 |
104 | Urticaria (HP:0001025) | 2.07874815 |
105 | Chest pain (HP:0100749) | 2.07377087 |
106 | Hypochromic microcytic anemia (HP:0004840) | 2.07151756 |
107 | Vertigo (HP:0002321) | 2.06230768 |
108 | Severe combined immunodeficiency (HP:0004430) | 2.06066480 |
109 | Skin ulcer (HP:0200042) | 2.05538902 |
110 | Acute hepatic failure (HP:0006554) | 2.05211670 |
111 | Combined immunodeficiency (HP:0005387) | 2.04257647 |
112 | Anorexia (HP:0002039) | 2.03766264 |
113 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02206297 |
114 | Osteolytic defects of the hand bones (HP:0009699) | 2.02206297 |
115 | Abnormality of eosinophils (HP:0001879) | 2.01846286 |
116 | Petechiae (HP:0000967) | 2.01780029 |
117 | Arthralgia (HP:0002829) | 2.01603726 |
118 | Abnormality of the fingertips (HP:0001211) | 2.01492385 |
119 | Keratoconjunctivitis (HP:0001096) | 2.00762725 |
120 | Hypoplasia of the thymus (HP:0000778) | 2.00429714 |
121 | Porencephaly (HP:0002132) | 1.99209413 |
122 | Sepsis (HP:0100806) | 1.97633642 |
123 | Prolonged bleeding time (HP:0003010) | 1.97556431 |
124 | Mitral stenosis (HP:0001718) | 1.94943199 |
125 | Abnormal platelet volume (HP:0011876) | 1.93499403 |
126 | Peritonitis (HP:0002586) | 1.91453494 |
127 | Loss of speech (HP:0002371) | 1.90849999 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TYK2 | 4.01546909 |
2 | MAP4K1 | 3.88148023 |
3 | FGFR4 | 3.02088255 |
4 | JAK3 | 3.00773685 |
5 | IKBKE | 2.87522576 |
6 | MAP3K14 | 2.86249111 |
7 | TBK1 | 2.83510699 |
8 | JAK1 | 2.73233333 |
9 | ERN1 | 2.73024849 |
10 | TXK | 2.58414746 |
11 | STK10 | 2.42848229 |
12 | BLK | 2.42839334 |
13 | KIT | 2.25588996 |
14 | TESK2 | 1.96631079 |
15 | PRPF4B | 1.96048425 |
16 | MAP3K13 | 1.95815213 |
17 | MAP3K10 | 1.90921993 |
18 | FGFR3 | 1.90891874 |
19 | IRAK4 | 1.83105148 |
20 | ZAP70 | 1.81312619 |
21 | TGFBR2 | 1.78103555 |
22 | TRIB3 | 1.71177138 |
23 | GRK7 | 1.69194262 |
24 | IKBKB | 1.67362747 |
25 | TNK2 | 1.66370349 |
26 | MAP3K11 | 1.64739987 |
27 | CSK | 1.62950391 |
28 | IRAK3 | 1.60700866 |
29 | ITK | 1.53700147 |
30 | PKN2 | 1.51061071 |
31 | EPHB1 | 1.50302684 |
32 | GRK6 | 1.45464472 |
33 | RIPK4 | 1.44144157 |
34 | LRRK2 | 1.40941797 |
35 | TAOK2 | 1.39712123 |
36 | HCK | 1.36075795 |
37 | SYK | 1.33965858 |
38 | CSF1R | 1.33540063 |
39 | LCK | 1.30878244 |
40 | TAOK1 | 1.29182267 |
41 | CDK12 | 1.26824314 |
42 | MARK3 | 1.23684830 |
43 | BTK | 1.23461932 |
44 | TTN | 1.23240530 |
45 | JAK2 | 1.21518908 |
46 | TAOK3 | 1.20517803 |
47 | PTK6 | 1.20291922 |
48 | SIK3 | 1.18401737 |
49 | RIPK1 | 1.15337068 |
50 | CHUK | 1.10697029 |
51 | MAP3K1 | 1.09420671 |
52 | BMPR2 | 1.09413436 |
53 | TEC | 1.06370471 |
54 | EEF2K | 1.04167461 |
55 | RPS6KA4 | 1.03033000 |
56 | EPHA3 | 1.01697768 |
57 | SIK1 | 0.93806066 |
58 | NME2 | 0.93663442 |
59 | NEK9 | 0.91683300 |
60 | PIM1 | 0.90609945 |
61 | MST4 | 0.90548944 |
62 | LYN | 0.86164441 |
63 | CAMK1D | 0.85701198 |
64 | NLK | 0.81731193 |
65 | STK4 | 0.80924379 |
66 | FES | 0.77044155 |
67 | PRKCQ | 0.73325316 |
68 | MAP2K3 | 0.72122087 |
69 | STK3 | 0.69340124 |
70 | CDC42BPA | 0.64114241 |
71 | SIK2 | 0.63772606 |
72 | TRPM7 | 0.63283551 |
73 | EGFR | 0.61191593 |
74 | CDK4 | 0.61068813 |
75 | FLT3 | 0.60456507 |
76 | CDK6 | 0.60346906 |
77 | MOS | 0.60194504 |
78 | PRKCH | 0.59451741 |
79 | PBK | 0.58832351 |
80 | PIK3CG | 0.58157464 |
81 | IRAK2 | 0.57893849 |
82 | SMG1 | 0.57825914 |
83 | PIM2 | 0.57803863 |
84 | YES1 | 0.56439507 |
85 | KDR | 0.55005068 |
86 | MAPK11 | 0.53661404 |
87 | BMX | 0.51224558 |
88 | MAP2K6 | 0.50108093 |
89 | MATK | 0.50083772 |
90 | PDGFRB | 0.48686104 |
91 | MAP3K7 | 0.47751820 |
92 | IRAK1 | 0.47541938 |
93 | TESK1 | 0.45612434 |
94 | FGR | 0.45442789 |
95 | ACVR1B | 0.45394749 |
96 | CAMK1G | 0.44214613 |
97 | ABL1 | 0.42444529 |
98 | PDK1 | 0.42339844 |
99 | ALK | 0.42191552 |
100 | SGK3 | 0.41417957 |
101 | CAMKK2 | 0.39668317 |
102 | MAP3K5 | 0.39056378 |
103 | MAP3K3 | 0.37882431 |
104 | MAPK4 | 0.36271251 |
105 | MAP3K8 | 0.35961548 |
106 | PRKD2 | 0.35309855 |
107 | BCKDK | 0.34254038 |
108 | MKNK2 | 0.33799971 |
109 | IGF1R | 0.33164458 |
110 | HIPK2 | 0.31176346 |
111 | PDPK1 | 0.30238060 |
112 | TGFBR1 | 0.29074252 |
113 | MAPK7 | 0.28567333 |
114 | STK24 | 0.28561170 |
115 | INSR | 0.28265856 |
116 | FYN | 0.28197281 |
117 | SCYL2 | 0.27371079 |
118 | PRKCD | 0.26465486 |
119 | MAPKAPK2 | 0.26324618 |
120 | EIF2AK2 | 0.25519698 |
121 | KSR2 | 0.24521319 |
122 | PAK4 | 0.24421077 |
123 | ADRBK2 | 0.23878658 |
124 | RPS6KA6 | 0.23637028 |
125 | CLK1 | 0.22406189 |
126 | MAP3K12 | 0.22222129 |
127 | RET | 0.21705226 |
128 | MAPK3 | 0.20795310 |
129 | MAP3K6 | 0.19754401 |
130 | DDR2 | 0.17407687 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91749158 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.88304714 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.76663110 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.66955945 |
5 | Measles_Homo sapiens_hsa05162 | 2.58811816 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.55646367 |
7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.47220401 |
8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36236713 |
9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15455635 |
10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.11383572 |
11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.05713428 |
12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.04225957 |
13 | Influenza A_Homo sapiens_hsa05164 | 2.02230304 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.00905022 |
15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89532839 |
16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.85927495 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80087223 |
18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76471618 |
19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76008218 |
20 | Legionellosis_Homo sapiens_hsa05134 | 1.73984451 |
21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.72281024 |
22 | Allograft rejection_Homo sapiens_hsa05330 | 1.69954874 |
23 | Pertussis_Homo sapiens_hsa05133 | 1.68128910 |
24 | Malaria_Homo sapiens_hsa05144 | 1.65660028 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62735011 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.62331185 |
27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61213160 |
28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50965082 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47439298 |
30 | Hepatitis C_Homo sapiens_hsa05160 | 1.43967553 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.38083066 |
32 | Hepatitis B_Homo sapiens_hsa05161 | 1.37514930 |
33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36155377 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.34957393 |
35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33108950 |
36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24574991 |
37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21624736 |
38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11913540 |
39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09829563 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09698428 |
41 | Lysosome_Homo sapiens_hsa04142 | 1.07709463 |
42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05947527 |
43 | Asthma_Homo sapiens_hsa05310 | 1.03449908 |
44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01339746 |
45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99692743 |
46 | Shigellosis_Homo sapiens_hsa05131 | 0.98488348 |
47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98197567 |
48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96448564 |
49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95656095 |
50 | Salmonella infection_Homo sapiens_hsa05132 | 0.95464833 |
51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.91741359 |
52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91503573 |
53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88464516 |
54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86869237 |
55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86738897 |
56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86317499 |
57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85379981 |
58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85168550 |
59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84926400 |
60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84539936 |
61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84172314 |
62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81790377 |
63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77418873 |
64 | Insulin resistance_Homo sapiens_hsa04931 | 0.75084584 |
65 | Platelet activation_Homo sapiens_hsa04611 | 0.72534355 |
66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70546494 |
67 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69222062 |
68 | Phagosome_Homo sapiens_hsa04145 | 0.68259905 |
69 | ABC transporters_Homo sapiens_hsa02010 | 0.67429068 |
70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66910519 |
71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65232133 |
72 | Amoebiasis_Homo sapiens_hsa05146 | 0.62331395 |
73 | Lysine degradation_Homo sapiens_hsa00310 | 0.62015089 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61571221 |
75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56862708 |
76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56773146 |
77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55517480 |
78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53029850 |
79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52574799 |
80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52365388 |
81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52172619 |
82 | Endocytosis_Homo sapiens_hsa04144 | 0.52093546 |
83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48394965 |
84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46606279 |
85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44247340 |
86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44159105 |
87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43405098 |
88 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40561927 |
89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39910148 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38763270 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38150015 |
92 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36818868 |
93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36303534 |
94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35854726 |
95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35006947 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34993762 |
97 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34232239 |
98 | Proteasome_Homo sapiens_hsa03050 | 0.34014409 |
99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33738650 |
100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33077254 |
101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.32552119 |
102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31604344 |
103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31551304 |
104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30246694 |
105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30085241 |
106 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29478396 |
107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28869164 |
108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28568825 |
109 | Prion diseases_Homo sapiens_hsa05020 | 0.27388540 |
110 | Prostate cancer_Homo sapiens_hsa05215 | 0.26131596 |
111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25262489 |
112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.25091166 |
113 | Peroxisome_Homo sapiens_hsa04146 | 0.24558142 |
114 | Bladder cancer_Homo sapiens_hsa05219 | 0.24097768 |
115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.16232866 |
116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.15876840 |
117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.12772777 |
118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.11923307 |
119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.11855669 |
120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11475871 |
121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.09604255 |
122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07672052 |